CIP
NVAX icon

Chartwell Investment Partners’s Novavax NVAX Stock Holding History

Chartwell Investment Partners’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,813
Closed -$1.96M – 433
2021
Q1 		$1.96M Buy
10,813
+8,759
+426% +$1.75M 0.06% 288
2020
Q4 		$229K Sell
2,054
-470
-19% -$50K 0.01% 419
2020
Q3 		$273K Buy
+2,524
New +$307K 0.01% 411

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Chartwell Investment Partners's NVAX Position: Q2 2021 in Review

Chartwell Investment Partners sold out of Novavax (NVAX) in Q2 2021, closing a stake of 10,813 shares — an estimated $1.96M sold.

Chartwell Investment Partners first reported a position in NVAX in Q3 2020 and held it in 3 quarters. The position peaked at $1.96M in Q1 2021. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

  • Chartwell Investment Partners reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
  • Chartwell Investment Partners sold 10,813 Novavax shares in Q2 2021, an estimated $1.96M.
  • Chartwell Investment Partners first reported a position in Novavax in Q3 2020 and held it in 3 quarters.
  • Chartwell Investment Partners's Novavax position peaked at $1.96M in Q1 2021.
  • 407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on Chartwell Investment Partners's 13F filing for Q2 2021, filed 19 Jul 2021.